Finishing off fibrils

Research output: Contribution to journalComment/debate

2 Scopus citations

Abstract

Bortezomib shows high activity in light chain amyloidosis. Responses occur rapidly and are seen in cardiac, renal, and hepatic disease. Toxicity in this fragile population is significant.

Original languageEnglish (US)
Pages (from-to)1456-1457
Number of pages2
JournalBlood
Volume114
Issue number8
DOIs
StatePublished - Nov 19 2009

    Fingerprint

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this